Synthetic Bacteria Help Treat Phenylketonuria in Mice
The genetically engineered probiotic, already in clinical trials, may ease patients’ strict dietary regimes.
Synthetic Bacteria Help Treat Phenylketonuria in Mice
Synthetic Bacteria Help Treat Phenylketonuria in Mice

The genetically engineered probiotic, already in clinical trials, may ease patients’ strict dietary regimes.

The genetically engineered probiotic, already in clinical trials, may ease patients’ strict dietary regimes.

biobusiness, drug development, biotech, cancer
Drug Approval Could Boost Research on Marijuana Treatment for Autism
Drug Approval Could Boost Research on Marijuana Treatment for Autism
Jessica Wright | Aug 17, 2018
Epidiolex, a cannabis-derived medicine for epilepsy, will prompt federal regulatory changes that could crack open access to study the plant.
The NIH Loosens Grip on Gene Therapy Trials
The NIH Loosens Grip on Gene Therapy Trials
Kerry Grens | Aug 16, 2018
The agency proposes ceding its scrutiny of these studies to the FDA.
Elephants Revived a “Zombie” Gene that May Fend Off Cancer
Elephants Revived a “Zombie” Gene that May Fend Off Cancer
Kerry Grens | Aug 15, 2018
DNA damage kick-starts what was once a defunct duplicated gene, which kills off injured cells.
Jury Finds Monsanto’s Roundup Responsible for Man’s Cancer
Jury Finds Monsanto’s Roundup Responsible for Man’s Cancer
Sukanya Charuchandra | Aug 13, 2018
A San Francisco court levels $289 Million in damages against the pesticide maker.
First RNAi Therapy Approved by FDA
First RNAi Therapy Approved by FDA
Kerry Grens | Aug 10, 2018
Alnylam’s patisiran interferes with the production of a mutated protein present in people with hereditary transthyretin amyloidosis.
Effort to Reproduce Cancer Studies Scales Down to 18 Papers
Effort to Reproduce Cancer Studies Scales Down to 18 Papers
Diana Kwon | Aug 1, 2018
The Reproducibility Project: Cancer Biology initially aimed to replicate the results of 50 high-impact research articles.
Opinion: Learning from Immunotherapy’s Recent Failures
Opinion: Learning from Immunotherapy’s Recent Failures
Luis Felipe Campesato | Aug 1, 2018
The promise of immunotherapy is real. We now need to figure out how to maximize the number of patients the approach benefits.
Third Retraction for Harvard Cancer Biologist
Third Retraction for Harvard Cancer Biologist
Katarina Zimmer | Jul 25, 2018
The move follows two major corrections to a 2011 Nature paper, in which researchers demonstrated that a natural compound selectively kills cancer cells.
Cancer Geneticist Quits After Harassment Allegations
Cancer Geneticist Quits After Harassment Allegations
Kerry Grens | Jul 17, 2018
Accusations that Nazneen Rahman bullied employees at the Institute of Cancer Research in the U.K. stretch back 12 years.